Cigna Group (NYSE:CI – Get Free Report) had its price target hoisted by investment analysts at Royal Bank Of Canada from $337.00 to $346.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the health services provider’s stock. Royal Bank Of Canada‘s price objective would indicate a potential upside of 27.75% from the stock’s previous close.
Other equities analysts have also issued reports about the stock. Raymond James Financial lowered shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Guggenheim cut their price objective on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $360.00 and set an “overweight” rating for the company in a research note on Thursday, November 12th. Finally, Jefferies Financial Group lifted their target price on shares of Cigna Group from $288.00 to $304.00 and gave the company a “hold” rating in a report on Thursday, November 12th. Fourteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $337.35.
Check Out Our Latest Analysis on CI
Cigna Group Stock Down 0.8%
Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. The company had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period last year, the firm earned $7.83 EPS. As a group, research analysts anticipate that Cigna Group will post 30.70 EPS for the current year.
Insider Activity at Cigna Group
In related news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. GQG Partners LLC bought a new stake in shares of Cigna Group in the 2nd quarter worth about $1,628,918,000. Bank of America Corp DE bought a new position in shares of Cigna Group during the second quarter worth about $827,692,000. Legal & General Group Plc bought a new position in shares of Cigna Group during the second quarter worth about $542,779,000. The Manufacturers Life Insurance Company acquired a new position in Cigna Group in the second quarter worth about $241,312,000. Finally, Aberdeen Group plc grew its stake in Cigna Group by 389.6% in the third quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock worth $283,907,000 after purchasing an additional 858,488 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Top Cigna Group Stories
Here are a few of the latest stories about CI:
- Positive Sentiment: Cigna’s latest reported quarter beat estimates: adjusted earnings were $7.98 per share versus a $7.52 consensus, and revenue rose 5.6% year over year to $73.79 billion. Cigna Q3 beat and outlook
- Neutral Sentiment: The Cigna Group Foundation announced $31.5 million in grants for community organizations across 10 states, supporting youth mental health, veterans, and people with complex health conditions. The announcement highlights community investment but provides no direct financial outlook update. Cigna Foundation grants
- Negative Sentiment: A proposed CMS rule would expand fraud oversight and reporting requirements across government health programs, raising regulatory and repayment concerns for managed-care stocks. Cigna sold its Medicare Advantage and Part D businesses in 2025, suggesting some of the pressure may reflect sector-wide sentiment rather than direct exposure. CMS rule and managed-care stocks
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
See Also
- Five stocks we like better than Cigna Group
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
